Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PT Interbat is a leading Indonesian pharmaceutical company established in 1948 and headquartered in Sidoarjo, East Java. The company specializes in the development, manufacturing, and marketing of a broad portfolio of over 200 pharmaceutical products, including prescription drugs, over-the-counter medicines, and health supplements. Interbat operates state-of-the-art manufacturing facilities that comply with international Good Manufacturing Practice (GMP) standards, ensuring high-quality production for both domestic and export markets. Its therapeutic focus spans diverse areas such as cardiology, gastroenterology, respiratory health, and infectious diseases. Recognized as one of the top pharmaceutical firms in Indonesia, Interbat maintains a robust distribution network and frequently partners with global healthcare entities for local market representation. The company remains a privately held, family-owned business dedicated to providing affordable and effective healthcare solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Interbat.